Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032
Overview
The Middle East & Africa Lysosomal Storage Disorder Drugs Market is expected to reach a 928.67 USD Million by 2032 and is projected to grow at a CAGR of 8.94% from 2025 to 2032.
Revenue, 2024 (USD Million)
510.05
Forecast, 2032 (USD Million)
928.67
CAGR, 2024 - 2032
8.94%
Report Coverage
Middle East & Africa
Middle East & Africa Lysosomal Storage Disorder Drugs Market 2018-2032 USD Million
Middle East & Africa Lysosomal Storage Disorder Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 510.05 USD Million
- Projected Market Size (2032): 928.67 USD Million
- CAGR (2025-2032): 8.94%
Key Findings of Middle East & Africa Lysosomal Storage Disorder Drugs Market
- The Middle East & Africa Lysosomal Storage Disorder Drugs Market was valued at 510.05 USD Million in 2024.
- The Middle East & Africa Lysosomal Storage Disorder Drugs Market is likely to grow at a CAGR of 8.94% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital Pharmacies in Distribution Channel Segment accounted for the largest share of the market with a revenue of 365.44 USD Million
- The fastest growing segment Imiglucerase in Drugs Segment grew Fastest with a CAGR of 10.64% during the forecast period from 2024 to 2032.
Middle East & Africa Lysosomal Storage Disorder Drugs Market Scope
Middle East & Africa Lysosomal Storage Disorder Drugs Market Segmentation & Scope
Type of Disorder
- Others
- Krabbe Disease
- Niemann-Pick Disease
- Mucopolysaccharidosis (MPS)
- Pompe Disease
- Fabry Disease
- Gaucher Disease
Type
- Others
- Chaperone Therapy
- Substrate Reduction Therapy (SRT)
- Enzyme Replacement Therapy (ERT)
Drugs
- Others
- Avalglucosidase Alfa
- Galsulfase
- Agalsidase Alpha
- Laronidase
- Taliglucerase Alfa
- Velaglucerase
- Alglucosidase Alpha
- Idursulfase
- Agalsidase Beta
- Imiglucerase
Route of Administration
- Others
- Oral
- Subcutaneous (SC)
- Intravenous (IV)
Age Group
- Geriatric
- Adults
- Pediatric
Gender
- Female
- Male
Distribution Channel
- Online Pharmacies
- Drugs Stores and Retail Pharmacies
- Hospital Pharmacies
Middle East & Africa Lysosomal Storage Disorder Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 510.05 USD Million |
| Market Value in 2032 | 928.67 USD Million |
| CAGR (2025-2032) | 8.94% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type of Disorder,Type,Drugs,Route of Administration,Age Group,Gender,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 510.05 USD Million in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 88.34 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Type of Disorder
- Gaucher Disease is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 209.14 USD Million in the year 2024.
- Gaucher Disease is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 9.62 % in forecast period 2025-2032.
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Type
- Enzyme Replacement Therapy (ERT) is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 348.90 USD Million in the year 2024.
- Substrate Reduction Therapy (SRT) is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 8.81 % in forecast period 2025-2032.
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Drugs
- Imiglucerase is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 151.49 USD Million in the year 2024.
- Imiglucerase is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 10.64 % in forecast period 2025-2032.
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Route of Administration
- Intravenous (IV) is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 315.55 USD Million in the year 2024.
- Subcutaneous (SC) is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 8.44 % in forecast period 2025-2032.
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Age Group
- Pediatric is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 242.67 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 9.72 % in forecast period 2025-2032.
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Gender
- Male is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 305.53 USD Million in the year 2024.
- Male is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 9.57 % in forecast period 2025-2032.
-
Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032, By Distribution Channel
- Hospital Pharmacies is the largest segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a revenue of 365.44 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in Middle East & Africa Lysosomal Storage Disorder Drugs Market to 2032 with a Growth rate of 9.05 % in forecast period 2025-2032.
Middle East & Africa Lysosomal Storage Disorder Drugs Market Company Share Analysis
| Company Name |
|
||
| Takeda Pharmaceutical Company Limited | |||
| Pfizer Inc. | |||
| Sanofi | |||
| BioMarin | |||
| Amicus Therapeutics, Inc. | |||
Middle East & Africa Lysosomal Storage Disorder Drugs Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Lysosomal Storage Disorder Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Lysosomal Storage Disorder Drugs Market is segmented based on Segmentation Type of Disorder,Type,Drugs,Route of Administration,Age Group,Gender,Distribution Channel.
Middle East & Africa Lysosomal Storage Disorder Drugs Market was valued at USD 510.05(Revenue in USD Million) in 2023.
Middle East & Africa Lysosomal Storage Disorder Drugs Market is projected to grow at a CAGR of 8.94% during the forecast period of 2024 to 2032.
The Hospital Pharmacies segment is expected to dominate the Middle East & Africa Lysosomal Storage Disorder Drugs Market, holding a largest market share of 365.44 USD Million in 2024
Middle East & Africa Lysosomal Storage Disorder Drugs Market Scope
Middle East & Africa Lysosomal Storage Disorder Drugs Market Segmentation & Scope
Type of Disorder
- Others
- Krabbe Disease
- Niemann-Pick Disease
- Mucopolysaccharidosis (MPS)
- Pompe Disease
- Fabry Disease
- Gaucher Disease
Type
- Others
- Chaperone Therapy
- Substrate Reduction Therapy (SRT)
- Enzyme Replacement Therapy (ERT)
Drugs
- Others
- Avalglucosidase Alfa
- Galsulfase
- Agalsidase Alpha
- Laronidase
- Taliglucerase Alfa
- Velaglucerase
- Alglucosidase Alpha
- Idursulfase
- Agalsidase Beta
- Imiglucerase
Route of Administration
- Others
- Oral
- Subcutaneous (SC)
- Intravenous (IV)
Age Group
- Geriatric
- Adults
- Pediatric
Gender
- Female
- Male
Distribution Channel
- Online Pharmacies
- Drugs Stores and Retail Pharmacies
- Hospital Pharmacies
Frequently Asked Questions
The Middle East & Africa Lysosomal Storage Disorder Drugs Market is segmented based on Segmentation Type of Disorder,Type,Drugs,Route of Administration,Age Group,Gender,Distribution Channel.
Middle East & Africa Lysosomal Storage Disorder Drugs Market was valued at USD 510.05(Revenue in USD Million) in 2023.
Middle East & Africa Lysosomal Storage Disorder Drugs Market is projected to grow at a CAGR of 8.94% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Lysosomal Storage Disorder Drugs Market for final year is USD 928.67 (USD Million).
Middle East & Africa Lysosomal Storage Disorder Drugs Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Lysosomal Storage Disorder Drugs Market is segmented based on Segmentation Type of Disorder,Type,Drugs,Route of Administration,Age Group,Gender,Distribution Channel.
Middle East & Africa Lysosomal Storage Disorder Drugs Market was valued at USD 510.05(Revenue in USD Million) in 2023.
Middle East & Africa Lysosomal Storage Disorder Drugs Market is projected to grow at a CAGR of 8.94% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Lysosomal Storage Disorder Drugs Market for final year is USD 928.67 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.